MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'bankruptcies'. Sun, 11 Oct 2009 21:27:33 +0100 http://www.medworm.com/index.php?rid=2452748&cid=t_216494_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2F7_WwNKsS9CU%2F Almost 2/3 of personal bankruptcies in the United States are the result of illness and overwhelming medical bills, despite having health insurance, say researchers. This is a 50% increase from 2001, just 8 years ago. And, it’s important to note 2 things. One is that bankruptcy is harder to declare now than it was before 2001 and that this research was done before the current economic situation, so the situation could, in fact, be worse. Researchers from Harvard Law School, Harvard Medical School and Ohio University worked together to produce the first known study of this type to cover the entire country. They found that the vast majority (over 77%) of the people who went bankrupt were among those who did have health insurance when they first became ill. According to a press release d... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2452748 Thu, 04 Jun 2009 10:30:21 +0100 2452748 http://www.medworm.com/index.php?rid=2021728&cid=t_216494_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F478522695%2F Severin Schwan has pulled out his crystal ball and sees a lot of trouble for the pharmaceutical industry, although not surprisingly, Roche does not appear in this particular vision. “Those who fail to bring sufficient innovation will be squeezed out of this market,” he tells The Wall Street Journal. “No one is immune to this failure. That applies equally to small companies and big companies.” To stave off his own failure, Schwan is boosting R&D spending as a percentage of its sales, in a bid to spur drug development. And he maintains Roche should be well-placed to succeed in the years ahead, because its cancer meds, including Herceptin and Avastin, are effective in many patients and, therefore, widely covered by insurers. Meanwhile, Joe Jimenez, who heads the p... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2021728 Mon, 08 Dec 2008 15:02:39 +0100 2021728